GR3022248T3 - Oligonucleotide sequences for amplification of type HIV-2 and SIV retroviruses genomes and their application to in-vitro diagnostic of infections caused by these viruses - Google Patents
Oligonucleotide sequences for amplification of type HIV-2 and SIV retroviruses genomes and their application to in-vitro diagnostic of infections caused by these virusesInfo
- Publication number
- GR3022248T3 GR3022248T3 GR970400012T GR970400012T GR3022248T3 GR 3022248 T3 GR3022248 T3 GR 3022248T3 GR 970400012 T GR970400012 T GR 970400012T GR 970400012 T GR970400012 T GR 970400012T GR 3022248 T3 GR3022248 T3 GR 3022248T3
- Authority
- GR
- Greece
- Prior art keywords
- genomes
- viruses
- amplification
- oligonucleotide sequences
- application
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- AIDS & HIV (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8907355A FR2647810B1 (fr) | 1989-06-02 | 1989-06-02 | Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3022248T3 true GR3022248T3 (en) | 1997-04-30 |
Family
ID=9382332
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR970400012T GR3022248T3 (en) | 1989-06-02 | 1997-01-09 | Oligonucleotide sequences for amplification of type HIV-2 and SIV retroviruses genomes and their application to in-vitro diagnostic of infections caused by these viruses |
Country Status (11)
Country | Link |
---|---|
US (1) | US6020123A (el) |
EP (1) | EP0404625B1 (el) |
JP (1) | JPH04505558A (el) |
AT (1) | ATE144558T1 (el) |
CA (3) | CA2341946C (el) |
DE (1) | DE69028951T2 (el) |
DK (1) | DK0404625T3 (el) |
ES (1) | ES2095241T3 (el) |
FR (1) | FR2647810B1 (el) |
GR (1) | GR3022248T3 (el) |
WO (1) | WO1990015158A1 (el) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2677039B1 (fr) * | 1991-05-31 | 1994-09-09 | Cis Bio Int | Oligonucleotides, utilisables comme reactifs pour la detection in vitro des infections a retrovirus de type hiv et procede de detection de retrovirus de type hiv. |
CN102134609A (zh) | 1994-10-20 | 2011-07-27 | 巴斯德研究所 | Hiv-1 o组(或亚组)逆转录病毒抗原的核苷酸序列 |
FR2731225B1 (fr) * | 1995-03-03 | 2003-10-31 | Pasteur Institut | Peptides de glycoproteine transmembranaire d'enveloppe et de proteine de capside du retrovirus humain du type hiv-1 et peptides presentant avec eux une parente immunologique |
US5962665A (en) * | 1997-06-16 | 1999-10-05 | Abbott Laboratories | Nucleic acid primers and probes for detecting HIV-1 and HIV-2 |
US6001558A (en) * | 1997-06-25 | 1999-12-14 | Ortho Clinical Diagnostics, Inc. | Amplification and detection of HIV-1 and/or HIV 2 |
DE60132924T2 (de) | 2000-10-23 | 2009-03-05 | Gen-Probe Inc., San Diego | Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2) |
WO2003062377A2 (en) * | 2002-01-17 | 2003-07-31 | The Uab Research Foundation | COMPLETE GENOME SEQUENCE OF SIVcpzTAN1 |
CA2547750C (en) | 2003-12-19 | 2014-04-08 | Gen-Probe Incorporated | Compositions, methods and kits for detecting the nucleic acids of hiv-1 and hiv-2 |
US8747862B2 (en) | 2008-11-14 | 2014-06-10 | Tulane University Health Sciences Center | Pathogenic west african human immunodeficiency virus type 2 (HIV-2) group F isolate |
CA2793959C (en) | 2010-03-25 | 2019-06-04 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
CA2832109C (en) | 2011-06-10 | 2021-07-06 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
AU2012216792A1 (en) | 2011-09-12 | 2013-03-28 | International Aids Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies |
EP2679596B1 (en) | 2012-06-27 | 2017-04-12 | International Aids Vaccine Initiative | HIV-1 env glycoprotein variant |
US20150065381A1 (en) | 2013-09-05 | 2015-03-05 | International Aids Vaccine Initiative | Methods of identifying novel hiv-1 immunogens |
EP2873423B1 (en) | 2013-10-07 | 2017-05-31 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
US10174292B2 (en) | 2015-03-20 | 2019-01-08 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
US9931394B2 (en) | 2015-03-23 | 2018-04-03 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE64006B1 (en) * | 1984-10-18 | 1995-06-28 | Pasteur Institut | Antigens particulary envelope antigens of the virus of lymphadenopathies and of the acquired immune-deficiency syndrome and virus process for producing virus envelope antigens use of said antigens in the preparation of immunogenic compositions or for the diagnosis of the presence of antibodies against this virus |
US4683195A (en) * | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
AU606043B2 (en) * | 1985-03-28 | 1991-01-31 | F. Hoffmann-La Roche Ag | Detection of viruses by amplification and hybridization |
ES2150897T3 (es) * | 1986-01-22 | 2000-12-16 | Pasteur Institut | Procedimiento de fabricacion recombinante de las proteinas derivadas de hiv-2 y cultivo celular que expresa proteinas de hiv-2. |
US4839288A (en) * | 1986-01-22 | 1989-06-13 | Institut Pasteur | Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes |
US4806463A (en) * | 1986-05-23 | 1989-02-21 | Worcester Foundation For Experimental Biology | Inhibition of HTLV-III by exogenous oligonucleotides |
US5030714A (en) * | 1986-06-23 | 1991-07-09 | Institut Pasteur | Variant of LAV viruses |
ATE88762T1 (de) * | 1986-08-11 | 1993-05-15 | Siska Diagnostics Inc | Methoden und zusammensetzungen fuer tests mit nukleinsaeuresonden. |
US5079351A (en) * | 1986-11-26 | 1992-01-07 | Cetus Corporation | Oligonucleotides and kits for detection of htlvi and htlvii viruses by hybridization |
ATE154808T1 (de) * | 1987-01-16 | 1997-07-15 | Pasteur Institut | Peptide mit den immunologischen eigenschaften von hiv-2 |
-
1989
- 1989-06-02 FR FR8907355A patent/FR2647810B1/fr not_active Expired - Lifetime
-
1990
- 1990-04-05 CA CA002341946A patent/CA2341946C/fr not_active Expired - Lifetime
- 1990-06-05 CA CA002592555A patent/CA2592555C/fr not_active Expired - Lifetime
- 1990-06-05 JP JP2509746A patent/JPH04505558A/ja active Pending
- 1990-06-05 WO PCT/FR1990/000394 patent/WO1990015158A1/fr active Application Filing
- 1990-06-05 EP EP90401521A patent/EP0404625B1/fr not_active Expired - Lifetime
- 1990-06-05 DK DK90401521.1T patent/DK0404625T3/da active
- 1990-06-05 DE DE69028951T patent/DE69028951T2/de not_active Expired - Lifetime
- 1990-06-05 CA CA002055612A patent/CA2055612C/fr not_active Expired - Lifetime
- 1990-06-05 ES ES90401521T patent/ES2095241T3/es not_active Expired - Lifetime
- 1990-06-05 AT AT90401521T patent/ATE144558T1/de not_active IP Right Cessation
-
1994
- 1994-11-18 US US08/343,998 patent/US6020123A/en not_active Expired - Lifetime
-
1997
- 1997-01-09 GR GR970400012T patent/GR3022248T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0404625A2 (fr) | 1990-12-27 |
CA2055612C (fr) | 2001-07-31 |
FR2647810B1 (fr) | 1994-07-22 |
WO1990015158A1 (fr) | 1990-12-13 |
CA2592555A1 (fr) | 1990-12-13 |
JPH04505558A (ja) | 1992-10-01 |
ES2095241T3 (es) | 1997-02-16 |
EP0404625A3 (fr) | 1991-01-16 |
DK0404625T3 (da) | 1997-03-10 |
ATE144558T1 (de) | 1996-11-15 |
DE69028951D1 (de) | 1996-11-28 |
CA2341946A1 (fr) | 1990-12-13 |
CA2592555C (fr) | 2010-01-05 |
EP0404625B1 (fr) | 1996-10-23 |
US6020123A (en) | 2000-02-01 |
CA2055612A1 (fr) | 1990-12-03 |
CA2341946C (fr) | 2007-10-23 |
DE69028951T2 (de) | 1997-05-07 |
FR2647810A1 (fr) | 1990-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1990015066A3 (fr) | Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour le diagnostic in vitro des infections dues a ces virus | |
GR3022248T3 (en) | Oligonucleotide sequences for amplification of type HIV-2 and SIV retroviruses genomes and their application to in-vitro diagnostic of infections caused by these viruses | |
SI0887427T1 (sl) | Pomnozevanje in detekcija HIV-1 in/ali HIV-2 | |
ATE135363T1 (de) | Nucleoside zur verwendung für die therapie | |
ES2062887T3 (es) | Secuencias de adn derivadas del genoma del papilomavirus hpv39, su aplicacion al diagnostico in vitro y a la produccion de preparado inmunogeno. | |
DK0495896T3 (da) | Vaccine til beskyttelse mod HIV-virusinfektioner, fremgangsmåde til fremstilling heraf og anvendelse heraf som diagnostisk middel og immunterapeutisk middel | |
DK0831899T3 (da) | Rekombinant koppevirus-calicivirus-præparater og anvendelser | |
MX9700414A (es) | Agentes antivirales de difluoroestatona. | |
WO1990013281A3 (en) | Method of suppressing hiv infection | |
ATE121779T1 (de) | Nichtzurückschlagende rns-viren. | |
DK76688A (da) | Vaccine indeholdende f-proteinet fra aids-virus | |
HU896176D0 (en) | Method for producing of protease, reverse transcriptase and endonuclease of retrovirus | |
FR2652091B1 (fr) | Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour le diagnostic in-vitro des infections dues a ces virus. | |
FI893346A0 (fi) | Icke-reverterande rna-virus. | |
EP1104770A3 (en) | Compositions and methods for detecting and treating acquired immunodeficiency syndrome | |
GR3035623T3 (en) | Macrocyclic difluorostatone derivatives useful as antiviral agents |